Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Liver Disease Treatment Market to reach USD XXX billion by the end of 2029.

Global Liver Disease Treatment Market Size study & Forecast, by Treatment Type (Antiviral Drugs, Immunosuppressants, Vaccines, Immunoglobulins, Corticosteroids, Targeted Therapy, Chemotherapy), by Disease Type (Hepatitis, Autoimmune Diseases, Non-alcoholic Fatty Liver Disease (NAFLD), Cancer, Genetic Disorders, Others) and Regional Analysis, 2022-2029

Product Code: HLSDT-99627088
Publish Date: 9-05-2023
Page: 200

Global Liver Disease Treatment Market is valued at approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. The liver is a crucial organ whose sole function is to process and eliminate potentially harmful body toxins. Any disease condition that causes liver inflammation and may impede the liver’s normal function is referred to as liver disease. Liver problems can be caused by infections, autoimmune disorders, using over-the-counter medications excessively, getting injured, drinking alcohol, and other factors. Immunoglobulin is also used to treat certain types of hepatitis. Alcohol consumption and an unhealthy lifestyle are the main causes of the rising prevalence of liver disorders such as non-alcoholic fatty liver disease (NAFLD), liver cirrhosis, hepatitis, and liver cancer worldwide. Additionally, an increase in elderly population around the world contributes to disease dysfunction. As a result, there has been an upsurge in hospital admissions for both hereditary genetic disorders and the different liver diseases indicated above. In addition, poor eating habits and unhealthy diet causes excess weight further leading to obesity. The two main factors contributing to fatty liver disease in adults are obesity and alcoholism. As a result of being overweight or obese, fat develops in the liver. This results in persistent inflammation and liver scarring (also known as cirrhosis). Obesity and non-alcoholic fatty liver disease are closely related. Excess fat leads to insulin resistance and inflammatory signals. Patients with high blood pressure, high cholesterol, excess body weight, diabetes, or insulin resistance are more susceptible to developing fatty liver disease.

Furthermore, owing to low immunity levels than adults, the geriatric population is more prone to liver illnesses. In addition, ageing has been shown to increase vulnerability to acute liver injury. Thus, the rising aging population is anticipated to support market growth during the forecast period. According to the World Bank, 8% of the total population aged 65 and older lived in the world in 2015, and in 2021 the rate reached 10 %. Additionally, the rising investments in R&D activities for the development of better liver disease treatment are anticipated to create a lucrative opportunity for the market during forecast period. However, the stringent regulatory approvals related to liver disease treatment drugs and vaccines stifle market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Liver Disease Treatment Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the dominating region across the world in terms of market share, owing to the presence of key players, rise in consumption of alcohol, unhealthy lifestyle leading to obesity & weight gain, and rise in healthcare expenditure in the region. Whereas, Asia Pacific is also anticipated to exhibit the highest growth rate over the forecast period, owing to factors such as increase in R&D activities, surge in liver diseases, unmet medical demands, and growing investments in the healthcare sector which would create lucrative growth prospects for the Liver Disease Treatment market across Asia Pacific region.

Major market players included in this report are:
Abbvie Inc.
Abbott Laboratories
Astellas Pharma Inc.
Bristol-Myers Squibb
Eli Lilly And Company
Emergent Biosolutions Inc. (Cangene Biopharma)
F. Hoffmann-La Roche Ag
Gilead Sciences, Inc.
Merck & Co. Inc.
Viatris Inc.

Recent Developments in the Market:
Ø April 2020, Alnylam Pharmaceuticals Inc. and Dicerna Pharmaceuticals Inc. collaborated to create and market investigational RNAi therapies for the treatment of liver disease caused by alpha-1 antitrypsin deficiency.

Global Liver Disease Treatment Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Treatment Type, Disease Type, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Treatment Type:
Antiviral Drugs
Immunosuppressants
Vaccines
Immunoglobulins
Corticosteroids
Targeted Therapy
Chemotherapy

By Disease Type:
Hepatitis
Autoimmune Diseases
Non-alcoholic Fatty Liver Disease (NAFLD)
Cancer
Genetic Disorders
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Liver Disease Treatment Market, by Region, 2019-2029 (USD Billion)
1.2.2. Liver Disease Treatment Market, by Treatment Type, 2019-2029 (USD Billion)
1.2.3. Liver Disease Treatment Market, by Disease Type, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Liver Disease Treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Liver Disease Treatment Market Dynamics
3.1. Liver Disease Treatment Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Growing incidence of liver diseases
3.1.1.2. Rising alcohol consumption and poor dietary habits
3.1.1.3. Surge in geriatric population
3.1.2. Market Challenges
3.1.2.1. Stringent regulatory approvals related to liver disease treatment drugs and vaccines
3.1.3. Market Opportunities
3.1.3.1. Rising Investment in R&D
Chapter 4. Global Liver Disease Treatment Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Liver Disease Treatment Market, by Treatment Type
6.1. Market Snapshot
6.2. Global Liver Disease Treatment Market by Treatment Type, Performance – Potential Analysis
6.3. Global Liver Disease Treatment Market Estimates & Forecasts by Treatment Type 2019-2029 (USD Billion)
6.4. Liver Disease Treatment Market, Sub Segment Analysis
6.4.1. Antiviral Drugs
6.4.2. Immunosuppressants
6.4.3. Vaccines
6.4.4. Immunoglobulins
6.4.5. Corticosteroids
6.4.6. Targeted Therapy
6.4.7. Chemotherapy
Chapter 7. Global Liver Disease Treatment Market, by Disease Type
7.1. Market Snapshot
7.2. Global Liver Disease Treatment Market by Disease Type, Performance – Potential Analysis
7.3. Global Liver Disease Treatment Market Estimates & Forecasts by Disease Type 2019-2029 (USD Billion)
7.4. Liver Disease Treatment Market, Sub Segment Analysis
7.4.1. Hepatitis
7.4.2. Autoimmune Diseases
7.4.3. Non-alcoholic Fatty Liver Disease (NAFLD)
7.4.4. Cancer
7.4.5. Genetic Disorders
7.4.6. Others
Chapter 8. Global Liver Disease Treatment Market, Regional Analysis
8.1. Liver Disease Treatment Market, Regional Market Snapshot
8.2. North America Liver Disease Treatment Market
8.2.1. U.S. Liver Disease Treatment Market
8.2.1.1. Treatment Type breakdown estimates & forecasts, 2019-2029
8.2.1.2. Disease Type breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Liver Disease Treatment Market
8.3. Europe Liver Disease Treatment Market Snapshot
8.3.1. U.K. Liver Disease Treatment Market
8.3.2. Germany Liver Disease Treatment Market
8.3.3. France Liver Disease Treatment Market
8.3.4. Spain Liver Disease Treatment Market
8.3.5. Italy Liver Disease Treatment Market
8.3.6. Rest of Europe Liver Disease Treatment Market
8.4. Asia-Pacific Liver Disease Treatment Market Snapshot
8.4.1. China Liver Disease Treatment Market
8.4.2. India Liver Disease Treatment Market
8.4.3. Japan Liver Disease Treatment Market
8.4.4. Australia Liver Disease Treatment Market
8.4.5. South Korea Liver Disease Treatment Market
8.4.6. Rest of Asia Pacific Liver Disease Treatment Market
8.5. Latin America Liver Disease Treatment Market Snapshot
8.5.1. Brazil Liver Disease Treatment Market
8.5.2. Mexico Liver Disease Treatment Market
8.5.3. Rest of Latin America Liver Disease Treatment Market
8.6. Rest of The World Liver Disease Treatment Market

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Abbvie Inc.
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Abbott Laboratories
9.2.3. Astellas Pharma Inc.
9.2.4. Bristol-Myers Squibb
9.2.5. Eli Lilly And Company
9.2.6. Emergent Biosolutions Inc. (Cangene Biopharma)
9.2.7. F. Hoffmann-La Roche Ag
9.2.8. Gilead Sciences, Inc.
9.2.9. Merck & Co. Inc.
9.2.10. Viatris Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now